1313441-88-1 Usage
Description
4-[1-(N-BOC-AMino)cyclopropyl]phenylboronic acid, pinacol ester is a chemical compound that features a cyclopropyl group attached to a phenylboronic acid moiety, with a pinacol ester functional group. 4-[1-(N-BOC-AMino)cyclopropyl]phenylboronic acid, pinacol ester is characterized by its potential reactivity and stability, making it a valuable intermediate in organic synthesis.
Uses
Used in Pharmaceutical Industry:
4-[1-(N-BOC-AMino)cyclopropyl]phenylboronic acid, pinacol ester is used as a synthetic intermediate for the development of fused pyridine compounds. These compounds are designed to inhibit the serine-threonine kinase AKT, which plays a crucial role in various cellular processes, including cell survival, growth, and metabolism. By targeting AKT, these fused pyridine compounds have the potential to be effective in treating cancer.
Additionally, the compound may be utilized in the synthesis of other bioactive molecules or as a reagent in various chemical reactions, contributing to the advancement of pharmaceutical research and drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 1313441-88-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,3,4,4 and 1 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1313441-88:
(9*1)+(8*3)+(7*1)+(6*3)+(5*4)+(4*4)+(3*1)+(2*8)+(1*8)=121
121 % 10 = 1
So 1313441-88-1 is a valid CAS Registry Number.
1313441-88-1Relevant articles and documents
Synthesis method of (4-(1-((tert-butoxycarbonyl)amino)cyclopropyl)phenyl)borate
-
Paragraph 0020; 0024-0026; 0030-0032; 0036-0037, (2020/06/17)
The invention discloses a synthesis method of (4-(1-((tert-butoxycarbonyl)amino)cyclopropyl)phenyl)borate. The preparation method comprises the following steps: S1, dissolving a compound A with a massof 1.5-200 g and a volume of 5-900 mmol in 20-2000 mL o
HETEROARYL COMPOUNDS AS BTK INHIBITORS AND USES THEREOF
-
, (2016/05/02)
The present invention relates to imidazo pyridine compounds, and pharmaceutically acceptable compositions thereof, useful as BTK inhibitors.
Substituted Benzo-Imidazo-Pyrido-Diazepine Compounds
-
, (2012/05/07)
The present invention relates to substituted benzo-imidazo-pyrido-diazepine compounds and methods of synthesizing these compounds. The present invention also relates to pharmaceutical compositions containing substituted benzo-imidazo-pyrido-diazepine compounds and methods of treating cell proliferative disorders, such as cancer, by administering these compounds and pharmaceutical compositions to subjects in need thereof.
